Mar
19
No Increased Risk Of Breast Cancer With Conjugated Estrogens Alone – New Data From The Women’s Health Initiative Study Show
March 19, 2008 | Leave a Comment
Wyeth Pharmaceuticals, a polarization of Wyeth (NYSE: WYE),
reports that background published today contained next to the
Journal of the American Medical Association (JAMA) show that in
the estrogen-alone sub-study of the Women’s Health Initiative
(WHI), conjugated estrogens 0.625 mg do not stretch breast cancer
regularity in postmenopausal [...]
